Loading the player… The U.S. Food and Drug Administration is expected to authorize Pfizer’s COVID-19 vaccine for youngsters ages 12 to 15 by next week, according to a federal official and a person familiar with the process, setting up shots for many before the beginning of the next school year. The announcement is set to… Read More: FDA expected to OK Pfizer vaccine for teens within week »
With plans to boost COVID-19 vaccine production into the billions of doses next year, Moderna is making major renovations at its Massachusetts manufacturing site that will more than double its size. The mRNA developer on Tuesday said it plans to renovate its manufacturing site in Norwood, Massachusetts, from “a production and lab space to an industrial technology… Read More: Moderna plans major expansion at Massachusetts manufacturing site to help… »
WEDNESDAY, April 28, 2021 — Only 13.5% of people will suffer systemic side effects after getting Pfizer’s coronavirus vaccine, a new study finds. These systemic symptoms include headache, fatigue and tenderness. Most side effects are mild and peak in the day after being vaccinated, and they only last for one to two days, according to… Read More: About 1 in 7 Who Get Pfizer Vaccine Will Have… »
Dive Brief: Primary care practices are playing a significant role in vaccinating people in the U.S. for COVID-19, according to a new survey from the Primary Care Collaborative and the Larry A. Green Center. The PCC surveyed more than 650 primary care physicians, nurse practitioners and pharmacists in 48 states, the District of Columbia and… Read More: Primary care plays bigger role in vaccine rollout as burnout… »